Journal profile · ONCOLOGY
JNCI-Journal of the National Cancer Institute
ISSN 0027-8874 · eISSN 1460-2105 · Oxford University Press · UNITED STATES
JNCI-Journal of the National Cancer Institute: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 7.66; hybrid open access; APC about USD 5,436; median 113 days to acceptance (96 articles, last 24 months); community-reported acceptance: hard; 392 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JNCI-Journal of the National Cancer Institute is published by Oxford University Press and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Global Cancer Incidence and Screening and Human auditory perception and evaluation, together about 21.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.
Source: LetPub
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.9%
- Global Cancer Incidence and ScreeningMedicine6.7%
- Human auditory perception and evaluationEngineering6.1%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.4%
- Educational Robotics and EngineeringComputer Science5%
- Cancer Risks and FactorsMedicine4.8%
- Advances in Oncology and RadiotherapyMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.66LetPub ·
- CiteScore 2026-06
- 12.3LetPub ·
- SJR 2026-06
- 3.79LetPub ·
- SNIP 2026-06
- 2.51LetPub ·
- h-index
- 333LetPub ·
- h-index
- 493OpenAlex ·
- i10-index
- 14,749OpenAlex ·
- 2-year mean citedness
- 4.54OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 35.29%LetPub ·
Volume
- Articles per year
- 220LetPub ·
Articles by year OpenAlex count · 32,844 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 327 | 145 | 148 |
| 2025 | 392 | 257 | 1,236 |
| 2024 | 348 | 309 | 3,465 |
| 2023 | 260 | 245 | 4,629 |
| 2022 | 226 | 223 | 5,497 |
| 2021 | 228 | 220 | 9,211 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
113 daysMedian, submission to acceptance · P25–P75 81 days – 149 days
- Acceptance to online
- median 19 days (71 articles)
- Submission to online
- median 126 days
- Sample
- 96 articles with submission and acceptance dates (908 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- HardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,436 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 0027-8874
- Electronic ISSN
- 1460-2105
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about JNCI-Journal of the National Cancer Institute
What CAS zone is JNCI-Journal of the National Cancer Institute in?
In the 2025 upgraded edition of the CAS Journal Ranking, JNCI-Journal of the National Cancer Institute is in Zone 1 of Medicine, and in Zone 1 of the minor category Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JNCI-Journal of the National Cancer Institute?
The latest impact factor listed by LetPub is 7.66; CiteScore 12.3, h-index 493.
How long does peer review take at JNCI-Journal of the National Cancer Institute?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 113 days (interquartile range 81–149 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index JNCI-Journal of the National Cancer Institute?
According to LetPub and DOAJ records, JNCI-Journal of the National Cancer Institute is indexed in SCIE and Scopus.
Is JNCI-Journal of the National Cancer Institute open access, and what is the APC?
JNCI-Journal of the National Cancer Institute is a hybrid journal. For open-access publication: APC about USD 5,436.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .